Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
Kevin J. Lee(University of Alabama at Birmingham), Gary A. Piazza(Auburn University), Elmar Nurmemmedov(Saint John's Health Center), Lori Coward(Samford University), Yulia Maxuitenko(Auburn University), Margie L. Clapper, Luciana Madeira da Silva(USA Mitchell Cancer Institute), Naga S. Annamdevula(University of South Alabama), Ashleigh Neese(USA Mitchell Cancer Institute), Wen‐Chi Chang(National Cheng Kung University), Silas J. Leavesley(University of Alabama), Adam B. Keeton(Washburn University), Tyler Mattox(USA Mitchell Cancer Institute), Antonio Ward(USA Mitchell Cancer Institute), Mary Pat Moyer(Incell Corporation (United States)), Alla Musiyenko(USA Mitchell Cancer Institute), Ashley S. Lindsey(USA Mitchell Cancer Institute), Ashley Nguyen(USA Mitchell Cancer Institute), Greg Gorman(Samford University), Joel Andrews(USA Mitchell Cancer Institute), Elaine Gavin(USA Mitchell Cancer Institute), Kristy Berry(USA Mitchell Cancer Institute), Harry S. Cooper(Fox Chase Cancer Center), Xi Chen(USA Mitchell Cancer Institute), Bing Zhu(China University of Geosciences (Beijing)), Charles Wood(Wake Forest University), Verónica Ramírez‐Alcántara(USA Mitchell Cancer Institute), Jacob Valiyaveettil(USA Mitchell Cancer Institute), Gang Zhou(Augusta University Health)
Cited by 19
Related Papers
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|998
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|846